AtriCure, Inc. (ATRC): Price and Financial Metrics

AtriCure, Inc. (ATRC): $31.94

0.20 (-0.62%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

ATRC Price/Volume Stats

Current price $31.94 52-week high $59.61
Prev. close $32.14 52-week low $29.67
Day low $31.49 Volume 606,000
Day high $32.53 Avg. volume 633,202
50-day MA $34.07 Dividend yield N/A
200-day MA $41.18 Market Cap 1.52B

ATRC Stock Price Chart Interactive Chart >

ATRC POWR Grades

  • Sentiment is the dimension where ATRC ranks best; there it ranks ahead of 76.31% of US stocks.
  • The strongest trend for ATRC is in Stability, which has been heading down over the past 26 weeks.
  • ATRC ranks lowest in Momentum; there it ranks in the 24th percentile.

ATRC Stock Summary

  • The price/operating cash flow metric for ATRICURE INC is higher than 99.89% of stocks in our set with a positive cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.29 for ATRICURE INC; that's greater than it is for only 16.56% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, ATRICURE INC is reporting a growth rate of -65.34%; that's higher than merely 20.18% of US stocks.
  • Stocks that are quantitatively similar to ATRC, based on their financial statements, market capitalization, and price volatility, are BRZE, CYRX, IOT, KTOS, and WEAV.
  • ATRC's SEC filings can be seen here. And to visit ATRICURE INC's official web site, go to www.atricure.com.

ATRC Valuation Summary

  • In comparison to the median Healthcare stock, ATRC's price/sales ratio is 4.76% higher, now standing at 4.4.
  • ATRC's price/sales ratio has moved down 11.7 over the prior 224 months.

Below are key valuation metrics over time for ATRC.

Stock Date P/S P/B P/E EV/EBIT
ATRC 2023-12-29 4.4 3.7 -68.2 -94.7
ATRC 2023-12-28 4.6 3.8 -70.1 -97.5
ATRC 2023-12-27 4.6 3.8 -70.8 -98.5
ATRC 2023-12-26 4.6 3.8 -71.2 -99.0
ATRC 2023-12-22 4.6 3.8 -70.8 -98.5
ATRC 2023-12-21 4.5 3.7 -68.7 -95.4

ATRC Growth Metrics

    The 2 year revenue growth rate now stands at 25.89%.
  • The 3 year price growth rate now stands at 82.01%.
  • Its year over year cash and equivalents growth rate is now at -67.04%.
Over the past 33 months, ATRC's revenue has gone up $84,762,000.

The table below shows ATRC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 315.569 -21.886 -56.037
2022-06-30 302.783 -20.334 53.343
2022-03-31 289.63 -29.096 51.933
2021-12-31 274.329 -13.78 50.199
2021-09-30 258.836 -10.127 45.378
2021-06-30 243.133 -6.083 -56.679

ATRC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ATRC has a Quality Grade of C, ranking ahead of 28.8% of graded US stocks.
  • ATRC's asset turnover comes in at 0.344 -- ranking 124th of 186 Medical Equipment stocks.
  • INGN, BSX, and GKOS are the stocks whose asset turnover ratios are most correlated with ATRC.

The table below shows ATRC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.344 0.746 -0.169
2021-03-31 0.301 0.729 -0.142
2020-12-31 0.311 0.723 -0.152
2020-09-30 0.337 0.722 -0.163
2020-06-30 0.361 0.722 -0.213
2020-03-31 0.463 0.736 -0.227

ATRC Price Target

For more insight on analysts targets of ATRC, see our ATRC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $96.71 Average Broker Recommendation 1.31 (Strong Buy)

AtriCure, Inc. (ATRC) Company Bio


Atricure provides atrial fibrillation solutions worldwide. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The company was founded in 2000 and is based in West Chester, Ohio.


ATRC Latest News Stream


Event/Time News Detail
Loading, please wait...

ATRC Latest Social Stream


Loading social stream, please wait...

View Full ATRC Social Stream

Latest ATRC News From Around the Web

Below are the latest news stories about ATRICURE INC that investors may wish to consider to help them evaluate ATRC as an investment opportunity.

Wall Street Analysts Predict a 36.34% Upside in AtriCure (ATRC): Here's What You Should Know

The consensus price target hints at a 36.3% upside potential for AtriCure (ATRC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | November 15, 2023

AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference

MASON, Ohio, November 15, 2023--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference.

Yahoo | November 15, 2023

AtriCure Releases 2023 ESG Report

MASON, Ohio, November 14, 2023--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company has published its 2023 Environmental, Social and Governance (ESG) Report highlighting the company’s corporate responsibility and sustainability initiatives.

Yahoo | November 14, 2023

All You Need to Know About AtriCure (ATRC) Rating Upgrade to Buy

AtriCure (ATRC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Yahoo | November 6, 2023

AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript

AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript November 1, 2023 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.3. Operator: Good afternoon, and welcome to AtriCure’s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end […]

Yahoo | November 2, 2023

Read More 'ATRC' Stories Here

ATRC Price Returns

1-mo -2.38%
3-mo -7.37%
6-mo -23.48%
1-year -18.08%
3-year -48.86%
5-year 11.68%
YTD -10.51%
2023 -19.58%
2022 -36.17%
2021 24.90%
2020 71.24%
2019 6.24%

Continue Researching ATRC

Here are a few links from around the web to help you further your research on AtriCure Inc's stock as an investment opportunity:

AtriCure Inc (ATRC) Stock Price | Nasdaq
AtriCure Inc (ATRC) Stock Quote, History and News - Yahoo Finance
AtriCure Inc (ATRC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!